The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus

S Simon, O Joean, T Welte… - European Respiratory …, 2023 - Eur Respiratory Soc
Exacerbations of COPD are associated with worsening of the airflow obstruction,
hospitalisation, reduced quality of life, disease progression and death. At least 70% of …

A pandemic lesson for global lung diseases: exacerbations are preventable

W Cookson, M Moffatt, G Rapeport… - American Journal of …, 2022 - atsjournals.org
A dramatic global reduction in the incidence of common seasonal respiratory viral infections
has resulted from measures to limit the transmission of severe acute respiratory syndrome …

Icenticaftor, a CFTR potentiator, in COPD: a multicenter, parallel-group, double-blind clinical trial

FJ Martinez, GJ Criner, C Gessner, M Jandl… - American Journal of …, 2023 - atsjournals.org
Rationale: CFTR (cystic fibrosis transmembrane conductance regulator) dysfunction is
associated with mucus accumulation and worsening chronic obstructive pulmonary disease …

Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates

FWS Ko, LHS Lau, SS Ng, TCF Yip, GLH Wong… - …, 2023 - Wiley Online Library
Background and objective Decline in hospitalizations for various respiratory diseases has
been reported during the COVID‐19 pandemic, but what led to such an observation is …

Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France

J Poucineau, T Delory, N Lapidus, G Hejblum… - Frontiers in …, 2022 - frontiersin.org
Background A global reduction in hospital admissions for acute exacerbations of chronic
obstructive pulmonary disease (AECOPD) was observed during the first months of the …

Impact of the COVID-19 pandemic on COPD exacerbations in Japanese patients: a retrospective study

T Nishioki, T Sato, A Okajima, H Motomura… - Scientific Reports, 2024 - nature.com
Various infection control measures implemented during the coronavirus disease (COVID-19)
pandemic have reduced the number of respiratory infections, which are the most common …

The impact of the SARS-CoV-2 pandemic on the demographic, clinical and social profiles of patients admitted to the Pneumology Department for a COPD …

A Fernández Villar, R Golpe Gómez… - PLoS …, 2023 - journals.plos.org
Introduction Although a reduction in admissions for pathologies other than SARS-CoV-2 has
been reported during the pandemic, there are hardly any specific studies in relation to …

Non-COVID-19 hospitalization and mortality during the COVID-19 pandemic in Iran: a longitudinal assessment of 41 million people in 2019–2022

M Razimoghadam, M Yaseri, M Rezaee, A Fazaeli… - BMC Public Health, 2024 - Springer
Background During a COVID-19 pandemic, it is imperative to investigate the outcomes of all
non-COVID-19 diseases. This study determines hospital admissions and mortality rates …

Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract …

T Ho, A Shahzad, A Jones, N Raghavan, M Loeb… - thorax, 2023 - thorax.bmj.com
Introduction Airway disease exacerbations are cyclical related to respiratory virus
prevalence. The COVID-19 pandemic has been associated with reduced exacerbations …

Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease

LC Myers, R Murray, B Donato, VX Liu, P Kipnis… - Respiratory …, 2023 - Elsevier
Background and objective Patients with chronic obstructive pulmonary disease (COPD) may
have worse coronavirus disease-2019 (COVID-19)–related outcomes. We compared COVID …